Suppr超能文献

冠状动脉造影期间冠状动脉血管痉挛的治疗

[Treatment of coronary artery vasospasm during coronary arteriography].

作者信息

Bernadet P, Marco J, Alibelli M J

出版信息

Arch Mal Coeur Vaiss. 1983 Feb;76 Spec No:123-9.

PMID:6407434
Abstract

Coronary spasm was first demonstrated by Gensini in 1962, and the diagnostic value of spontaneous spasm during coronary angiography is now generally accepted. In its absence, provocation tests with ergonovine or its derivatives form part of routine hemodynamic investigation for confirming the spastic nature of atypical chest pain or pain suggestive of Prinzmetal angina. The coronary spasm so induced gives rise to reduced coronary flow, an increase in coronary resistance and myocardial ischemia as shown by an increased lactate extraction in coronary sinus blood; therefore, once it is documented, it must be treated in order to avoid myocardial necrosis or ventricular arrhythmias. Three groups of drugs of drugs are used to counteract spontaneous or provoked spasm: alpha-blockers, especially phentolamine, nitrate derivatives, trinitroglycerine or isosorbide dinitrate, and calcium inhibitors nifedipine or diltiazem, which have a direct antispastic effect. The hemodynamic and pharmacological actions of these three groups of drugs depend on whether they are given orally, intravenously or by intracoronary injection. Twenty six coronary spasms were observed in 23 patients out of a total of 780 coronary angiographies (3,3 per cent) performed between June 1980 and June 1981: 12 spasms were spontaneous (1,5 per cent), 6 provoked by the catheter (0,8 per cent) and 8 by methylergometrine. There were no complications. Five coronary spasms were also observed during 70 coronary angioplasties (7,1 per cent). The spasm was relieved in all cases by intravenous injection of 1,5 to 3 mg of trinitrin (Lenitral). Calcium inhibitors, especially nifedipine, have been used successfully by Hugenholtz and Bertrand who consider that nifedipine has a slower action and the coronary dilatation obtained is never as great with the nitrate derivatives. Trinitrin remains the treatment of choice for the rapid relief of provoked spasm.

摘要

1962年,詹西尼首次证实了冠状动脉痉挛,冠状动脉造影期间自发性痉挛的诊断价值如今已被普遍接受。在未出现自发性痉挛的情况下,使用麦角新碱或其衍生物进行激发试验是常规血液动力学检查的一部分,用于确认非典型胸痛或疑似变异型心绞痛的疼痛的痉挛性质。如此诱发的冠状动脉痉挛会导致冠状动脉血流减少、冠状动脉阻力增加以及心肌缺血,如冠状窦血中乳酸摄取增加所示;因此,一旦记录到痉挛,就必须进行治疗,以避免心肌坏死或室性心律失常。有三类药物用于对抗自发性或诱发性痉挛:α受体阻滞剂,尤其是酚妥拉明;硝酸盐衍生物,如硝酸甘油或二硝酸异山梨酯;以及钙抑制剂硝苯地平或地尔硫䓬,它们具有直接的抗痉挛作用。这三类药物的血液动力学和药理作用取决于给药方式是口服、静脉注射还是冠状动脉内注射。在1980年6月至1981年6月期间进行的总共780例冠状动脉造影中,在23例患者中观察到26次冠状动脉痉挛(3.3%):12次痉挛是自发性的(1.5%),6次是由导管诱发的(0.8%),8次是由甲基麦角新碱诱发的。没有出现并发症。在70例冠状动脉成形术中也观察到5次冠状动脉痉挛(7.1%)。所有病例中,静脉注射1.5至3毫克三硝酸甘油(硝酸甘油)后痉挛均得到缓解。休根霍兹和贝特朗成功使用了钙抑制剂,尤其是硝苯地平,他们认为硝苯地平起效较慢,所获得的冠状动脉扩张效果不如硝酸盐衍生物显著。硝酸甘油仍然是迅速缓解诱发性痉挛的首选治疗药物。

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验